S.BIOMEDICS Investigational Cell Therapy for Parkinson’s Disease With TED-A9 Shows Positive Data at 12-months in Phase 1/2a Clinical Trial

View Full Size 

Download

• Full Size JPEG, 600x140, 29.2 KB
• Small JPEG, 480x112, 20.3 KB
• Preview JPEG, 144x34, 4.2 KB
• Thumbnail JPEG, 120x28, 3.0 KB